Co-Diagnostics, Inc. Payments to Acquire Real Estate and Real Estate Joint Ventures
Co-Diagnostics, Inc. (CODX) reported Payments to Acquire Real Estate and Real Estate Joint Ventures of $150.00 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Investing Activities
us-gaap:PaymentsToAcquireRealEstateAndRealEstateJointVentures · last filed 2026-08-13
- 2026-06-30: Payments to Acquire Real Estate and Real Estate Joint Ventures 6 month $150.00K.
| Period end | Payments to Acquire Real Estate and Real Estate Joint Ventures 6 month |
|---|---|
| 2026-06-30 | $150.00K 10-Q · filed 2026-08-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| enVVeno Medical Corp (NVNO) | United States | $0.006B | -0.48 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| ALLURION TECHNOLOGIES, INC. (ALUR) | United States | $0.010B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Picard Medical, Inc. (PMI) | United States | $0.011B | -0.01 |